Abiopharma

🔍 Furber Sara (Executive)

Company: Tradeweb Markets Inc. (TW)

Report Date: 2026-03-20

Detailed Transactions and Holdings:

• Sold 4,911 shares of Class A common stock at $125.1319 per share (Direct)
  Date: 2026-03-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 23,878.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Sold 1,614 shares of Class A common stock at $124.86 per share (Direct)
  Date: 2026-03-23 | Code: S | equity_swap_involved: 0 | shares_owned_after: 22,264.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 3, 2025.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.31 to $125.77, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F3: This amount includes (i) 3,716 unvested restricted stock units ("RSUs") in respect of the issuer's Class A common stock ("Class A Common Stock") that are scheduled on March 15, 2027, (ii) 6,573 unvested RSUs in respect of Class A Common Stock that are scheduled to vest in equal installments on March 17, 2027 and March 17, 2028 and (iii) 11,975 unvested RSUs in respect of Class A Common Stock that are scheduled to vest in equal installments on March 15, 2027, March 15, 2028 and March 15, 2029, in each case, subject to the reporting person's continued employment through the applicable vesting date.